Results 111 to 120 of about 1,598,056 (300)

L2/L3 equipment deployment scheme in PTN network architecture

open access: yesDianxin kexue, 2017
Relying on technological superiority,packet transport network(PTN)technology has become the main force in the construction of the transport network.In the early PTN network architecture,the L2/L3 equipment was deployed in the core layer.Therefore,it will
Xu DENG
doaj  

Gear Load Capacity [PDF]

open access: yesJournal of Applied Mechanics, 1963
W. A. Tuplin, E. L. Broghamer
openaire   +1 more source

E2A selectively regulates TGF‐β–induced apoptosis in KRAS‐mutant non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Ability to induce apoptosis by TGF‐β is frequently lost in advanced lung adenocarcinoma despite intact TGF‐β signaling. We identify E2A as a mutant KRAS–dependent mediator of resistance to TGF‐β–induced apoptosis. TGF‐β induces E2A via SMAD3 in mutant KRAS cells, and E2A silencing restores apoptosis and enhances radiation response in cell lines ...
Sergei Chuikov   +3 more
wiley   +1 more source

Forward Reliability Markets: Less Risk, Less Market Power, More Efficiency [PDF]

open access: yes
A forward reliability market is presented. The market coordinates new entry through the forward procurement of reliability options—physical capacity bundled with a financial option to supply energy above a strike price.
Peter Cramton, Steven Stoft
core  

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau   +8 more
wiley   +1 more source

Access by Capacity and Peak-Load Pricing [PDF]

open access: yes
Several European telecommunications regulatory agencies have recently introduced a fixed capacity charge (flat rate) to regulate access to the incumbents network.
Joan Calzada Aymerich
core   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Soil shear strength as a function of NSPT via Van der Veen extrapolation

open access: yesREM: International Engineering Journal
In this study, a ground anchored wall located in Belo Horizonte containing 295 anchorages in a sandy silt soil was analyzed. The load capacity of all the anchors was calculated by extrapolation of the receipt tests by the Van der Veen method through the ...
Luma Alvarenga Carvalho de Vasconcelos   +2 more
doaj   +1 more source

Cell‐cycle‐specific lesion evolution rather than inhibition of double‐strand‐break repair underpins cisplatin radiosensitization

open access: yesMolecular Oncology, EarlyView.
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu   +10 more
wiley   +1 more source

Innovative design of composite structures: Use of curvilinear fiber format to improve structural efficiency [PDF]

open access: yes
To increase the effectiveness and efficiency of fiber-reinforced materials, the use of fibers in a curvilinear rather than the traditional straightline format is explored.
Charette, R. F., Hyer, M. W.
core   +1 more source

Home - About - Disclaimer - Privacy